KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Goodwill (2016 - 2019)

Arbutus Biopharma's Goodwill history spans 4 years, with the latest figure at $24.4 million for Q1 2018.

  • For Q1 2018, Goodwill changed N/A year-over-year to $24.4 million; the TTM value through Mar 2018 reached $24.4 million, changed N/A, while the annual FY2017 figure was $24.4 million, 0.0% changed from the prior year.
  • Goodwill for Q1 2018 was $24.4 million at Arbutus Biopharma, roughly flat from $24.4 million in the prior quarter.
  • Across five years, Goodwill topped out at $162.5 million in Q4 2015 and bottomed at $24.4 million in Q4 2016.
  • The 4-year median for Goodwill is $156.3 million (2015), against an average of $119.2 million.
  • The largest YoY upside for Goodwill was 4.27% in 2016 against a maximum downside of 85.01% in 2016.
  • A 4-year view of Goodwill shows it stood at $162.5 million in 2015, then tumbled by 85.01% to $24.4 million in 2016, then changed by 0.0% to $24.4 million in 2017, then changed by 0.0% to $24.4 million in 2018.
  • Per Business Quant, the three most recent readings for ABUS's Goodwill are $24.4 million (Q1 2018), $24.4 million (Q4 2017), and $24.4 million (Q4 2016).